Related Experiment Videos
Second-line chemotherapy in epithelial ovarian carcinoma: platinum again? Taxanes? How to choose?
1Department of Medical Oncology, Centre Léon-Bérard, Lyon, France.
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma].
La Revue de medecine interne·2011
Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists.
European journal of cancer care·2010
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes.
Annals of oncology : official journal of the European Society for Medical Oncology·2009
SOR guidelines for concomitant chemoradiotherapy for patients with uterine cervical cancers: evidence update bulletin 2004.
Annals of oncology : official journal of the European Society for Medical Oncology·2005
Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy.
European journal of cancer (Oxford, England : 1990)·2005
What does addressing cancer inequalities really mean? Five principles that can drive global action.
European journal of cancer (Oxford, England : 1990)·2026
Acute and long-term outcomes of CD20-targeting CAR T-cell therapy in relapsed or refractory B-NHL: MB-CART20.1 Lymphoma phase I trial.
European journal of cancer (Oxford, England : 1990)·2026
Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women.
European journal of cancer (Oxford, England : 1990)·2026
Systemic inflammation and patient-reported quality of life as combined prognosticators in patients with solid tumors.
European journal of cancer (Oxford, England : 1990)·2026
Analysis of quality-adjusted time without symptoms or toxicity (Q-TWiST) in patients with metastatic hormone-sensitive prostate cancer from the ARASENS trial.
European journal of cancer (Oxford, England : 1990)·2026
Lazertinib plus pemetrexed and carboplatin in patients with EGFR-mutant advanced non-small cell lung cancer after progression on lazertinib.
European journal of cancer (Oxford, England : 1990)·2026
Liver-resident cellular determinants of oncolytic virotherapy in hepatocellular carcinoma: viral susceptibility and spatial immune remodeling.
Frontiers in cell and developmental biology·2026
Chemokines as regulators of CAR-T cell trafficking, function, and context-dependent tumor cell death.
Frontiers in immunology·2026
Efficacy of the Peritoneovenous Shunt as Palliative Care for Patients with Advanced Cancer with Refractory Ascites: A Randomized Controlled Trial (JIVROSG-0803 Study).
Interventional radiology (Higashimatsuyama-shi (Japan)·2026